| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/24/2004 | US6696055 Disinfectant substance comprising an iodine impregnated resin for use in sterilizing a fluid such as water or air |
| 02/24/2004 | CA2219081C Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/24/2004 | CA2102036C Vaccines raising an immunological response against the disease caused by the iowa strain of porcine reproductive and respiratory syndrome virus |
| 02/23/2004 | CA2399630A1 Scyphostatin analogues as smase inhibitors |
| 02/19/2004 | WO2004015122A1 Method for reproducing pleuromutilins |
| 02/19/2004 | WO2004015106A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 02/19/2004 | WO2004015062A2 Methods and compositions relating to gene silencing |
| 02/19/2004 | WO2004014958A1 Polysaccharide of echinacea angustifolia |
| 02/19/2004 | WO2004014957A1 Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes |
| 02/19/2004 | WO2004014936A2 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 02/19/2004 | WO2004014928A2 Novel difluorinated gem compounds, preparation methods thereof and applications of same |
| 02/19/2004 | WO2004014922A1 3-(carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitors |
| 02/19/2004 | WO2004014920A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/19/2004 | WO2004014913A2 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 02/19/2004 | WO2004014911A1 Phosphodiesterase 4 inhibitors |
| 02/19/2004 | WO2004014897A1 N-aryl-2-oxazolidinones and their derivatives |
| 02/19/2004 | WO2004014893A2 Antimicrobial aza-bicyclic derivates, their compositions and uses |
| 02/19/2004 | WO2004014864A1 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors |
| 02/19/2004 | WO2004014861A1 4-substituted-quinoline-8-carboxylic amide derivatives and pharmacologically acceptable addition salts thereof |
| 02/19/2004 | WO2004014859A2 Process for preparing quinolin antibiotic intermediates |
| 02/19/2004 | WO2004014831A1 Polyisoprenylbenzophenone derivatives, method for production and use thereof |
| 02/19/2004 | WO2004014825A1 Cannabinoid receptor ligands |
| 02/19/2004 | WO2004014423A1 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody |
| 02/19/2004 | WO2004014420A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 02/19/2004 | WO2004014408A1 Intravaginal washing agent |
| 02/19/2004 | WO2004014400A1 Antimicrobial charged polymers that exhibit resistance to lysomal degradation during kidney filtration and renal passage, compositions and method of use thereof |
| 02/19/2004 | WO2004014398A1 The use of n-acetyl-d-glucosamine for preparing medicines for urogenital tract infection’s treatment and prevention |
| 02/19/2004 | WO2004014396A1 Medicament comprising fluocinolone and dexamethasone and/or hydrocortisone and gentamicin and/or neomycin |
| 02/19/2004 | WO2004014392A1 Oxazolidinone derivatives as antimicrobials |
| 02/19/2004 | WO2004014374A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/19/2004 | WO2004014371A1 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors |
| 02/19/2004 | WO2004014361A1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 02/19/2004 | WO2004014359A1 Regulation of apob in treatment and drug screening for cardiovascular and metabolic disorders or syndromes |
| 02/19/2004 | WO2004014349A1 New molecules for modulating drug resistance in fungus |
| 02/19/2004 | WO2004014338A1 Composition and method for rectal delivery of a lincosamide antibacterial drug |
| 02/19/2004 | WO2004014304A2 Electrospun amorphous pharmaceutical compositions |
| 02/19/2004 | WO2004014295A2 Tiacumicin production |
| 02/19/2004 | WO2004014146A1 The use of fermented wheat-germ in the feeding and veterinary practice |
| 02/19/2004 | WO2004007726A3 Brachyspira hyodysenteriae vaccine |
| 02/19/2004 | WO2004007481A3 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 02/19/2004 | WO2004006953A3 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |
| 02/19/2004 | WO2003101995A3 Camptothecins with a modified lactone ring |
| 02/19/2004 | WO2003088994A3 Modified vaccinia virus ankara for the vaccination of neonates |
| 02/19/2004 | WO2003070188A3 Method of treating trx mediated diseases |
| 02/19/2004 | WO2003065988A3 A combination for treating cold and cough |
| 02/19/2004 | WO2003065987A3 Granzyme b inhibitors |
| 02/19/2004 | WO2003065975A3 Processes for preparing crystalline and amorphous mupirocin calcium |
| 02/19/2004 | WO2003059251A3 Antibody targeting compounds |
| 02/19/2004 | WO2003052051A3 Adeno-associated virus (aav) serotype 8 sequences |
| 02/19/2004 | WO2003048780A3 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis |
| 02/19/2004 | WO2003025014A3 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies |
| 02/19/2004 | WO2003014731A3 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 02/19/2004 | WO2003008537A9 Epitope sequences |
| 02/19/2004 | WO2002097072A8 Influenza vaccine composition |
| 02/19/2004 | WO2002086101A3 Core-glycosylated hcv envelope proteins |
| 02/19/2004 | WO2002086100A3 Expression of core-glycosylated hcv envelope proteins in yeast |
| 02/19/2004 | WO2002061086A3 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 02/19/2004 | WO2002056895A3 Ionene polymers and their use in treating mucositis |
| 02/19/2004 | WO2002048337A3 Secreted human proteins |
| 02/19/2004 | WO2002048184A8 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test |
| 02/19/2004 | WO2002042328A3 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 02/19/2004 | WO2002032920A3 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 02/19/2004 | WO2002028888A3 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same |
| 02/19/2004 | WO2001020981A3 Anti-infective compositions for treating disordered tissue such as cold sores |
| 02/19/2004 | US20040034232 Amide derivative |
| 02/19/2004 | US20040034229 3,4-Di-substituted maleimide compounds as CXC chemokine receptor antagonists |
| 02/19/2004 | US20040034221 Enzyme inhibitors for treating AIDS |
| 02/19/2004 | US20040034218 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 02/19/2004 | US20040034216 A gonane ring or with the nitrogen forming a heterocyclic structure; antiinflammation agents, antitumor agents; treating asthma, allergic disease, chronic obstructive pulmonary disease, atopic dermatitis, AIDS, arrhythmias |
| 02/19/2004 | US20040034103 Cdc25 photophatase inhibitors |
| 02/19/2004 | US20040034090 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors |
| 02/19/2004 | US20040034084 Side effect reduction; for treatment of AIDS, cancer and arthritis |
| 02/19/2004 | US20040034056 Method of preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide |
| 02/19/2004 | US20040034055 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 02/19/2004 | US20040034047 E.g. 5-(6,7-dimethoxy-2-(4-methoxybenzyl)benzofuran-4-yl-methyl-)pyrimidine-2,4 -diamine; bactericides for infections of grampositive and gramnegative pathogens; more potent than Trimethoprim, especially against respiratory tract pathogens |
| 02/19/2004 | US20040034041 Novel anti-infectives |
| 02/19/2004 | US20040034034 Novel piperazine derivatives |
| 02/19/2004 | US20040034020 A purine deriveative, useful for treatment of inflammatory conditions, immune disorders, tissue injury, infections, and cancer |
| 02/19/2004 | US20040034016 Diuretic or sulphonylurea for use in antiviral treatment |
| 02/19/2004 | US20040033996 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 02/19/2004 | US20040033995 Nitrogen compounds, stereoisomers and/or racemic mixtures used as enzyme inhibitors for prophylaxis of inflammatory diseases |
| 02/19/2004 | US20040033994 Use of compounds comprising a nitrogen-oxygen heterocycle |
| 02/19/2004 | US20040033986 Anti tubercular drug: compositions and methods |
| 02/19/2004 | US20040033982 Viral inhibition by n-docosanol |
| 02/19/2004 | US20040033980 Method of down-regulating gene expression |
| 02/19/2004 | US20040033978 Antisense oligonucleotides complementary to and that hybridize with RNA, used for gene expression inhibition, prophylaxis and medical diagnosis |
| 02/19/2004 | US20040033977 Oligonucleotide modulation of cell adhesion |
| 02/19/2004 | US20040033964 For treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation |
| 02/19/2004 | US20040033959 Improved bioavailability |
| 02/19/2004 | US20040033952 Modified mature insulin variants and composition containing same |
| 02/19/2004 | US20040033951 Modified mature insulin variants and composition containing same |
| 02/19/2004 | US20040033946 Cell damage inhibitor |
| 02/19/2004 | US20040033939 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/19/2004 | US20040033595 Conditionally replicating vectors for inhibiting viral infections |
| 02/19/2004 | US20040033586 Pasteurella and/or actinobacillus mutant coding polypeptide for prevention and treatment of infectious disease; veterinary medicine |
| 02/19/2004 | US20040033563 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 02/19/2004 | US20040033517 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (PAR1) |
| 02/19/2004 | US20040033511 Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines) |
| 02/19/2004 | US20040033487 Comprises nucleotide sequences coding associated with glycosylation of viral structural polypeptides; prototype immunogens for treatment and prevention of viral disease; genetic vaccines |
| 02/19/2004 | US20040033240 Immunological combinations for prophylaxis and therapy of helicobacter pylori infection |